The Complex Connection between Cannabis and Schizophrenia
The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship. Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia. - Synthesizes existing knowledge about the confusing, but crucial, relationship between cannabis use and schizophrenia symptoms - Provides a comprehensive overview of the neurobiological mechanisms of cannabis use and its effects on the brain, including an exploration of the endocannabinoid system - Examines the promising evidence suggesting cannabidiol as an effective antipsychotic treatment for schizophrenia - Aids readers studying the neurobiological underpinning of cannabis addiction and psychosis in determining directions for their own future research
1133479939
The Complex Connection between Cannabis and Schizophrenia
The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship. Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia. - Synthesizes existing knowledge about the confusing, but crucial, relationship between cannabis use and schizophrenia symptoms - Provides a comprehensive overview of the neurobiological mechanisms of cannabis use and its effects on the brain, including an exploration of the endocannabinoid system - Examines the promising evidence suggesting cannabidiol as an effective antipsychotic treatment for schizophrenia - Aids readers studying the neurobiological underpinning of cannabis addiction and psychosis in determining directions for their own future research
79.95 In Stock
The Complex Connection between Cannabis and Schizophrenia

The Complex Connection between Cannabis and Schizophrenia

The Complex Connection between Cannabis and Schizophrenia

The Complex Connection between Cannabis and Schizophrenia

eBook

$79.95 

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

The Complex Connection between Cannabis and Schizophrenia provides an in-depth overview of the current state of research into the role that cannabis plays in schizophrenia, covering both the pathophysiological and the pharmacological implications. It addresses the epidemiology of cannabis use and the risks associated with its use, the biological aspects of the drug, its effects on the brain and the pharmacological possibilities of using cannabidiol to treat schizophrenia. It is the only book on the market devoted exclusively to examining the links between this very commonly used (and misused) drug and a specific set of devastating psychiatric illnesses, providing a comprehensive guide to our current understandings of this relationship. Marijuana is the most commonly used illicit drug globally, and is becoming increasingly decriminalized and even legalized worldwide. Among the numerous mental-health concerns related to the drug, there is mounting evidence of an intricate link between cannabis use and schizophrenia and related psychotic disorders. At the same time, there is promising evidence to suggest that cannabidiol, one of the many compounds found in cannabis that activates the brain's cannabinoid receptors, could prove to be an effective antipsychotic to treat schizophrenia. - Synthesizes existing knowledge about the confusing, but crucial, relationship between cannabis use and schizophrenia symptoms - Provides a comprehensive overview of the neurobiological mechanisms of cannabis use and its effects on the brain, including an exploration of the endocannabinoid system - Examines the promising evidence suggesting cannabidiol as an effective antipsychotic treatment for schizophrenia - Aids readers studying the neurobiological underpinning of cannabis addiction and psychosis in determining directions for their own future research

Product Details

ISBN-13: 9780128051832
Publisher: Elsevier Science & Technology Books
Publication date: 08/25/2017
Sold by: Barnes & Noble
Format: eBook
Pages: 362
File size: 14 MB
Note: This product may take a few minutes to download.

About the Author

Professor of Clinical Psychiatry, Columbia University College of Physicians and Surgeons, NY, USA
Clinical Assistant Professor of Psychiatry, New York University School of Medicine, NY USA

Table of Contents

1. Introduction to the Complex Connection between Cannabis Use and Psychosis, Psychotic Disorders, and SchizophreniaMarc W. Manseau and Michael T. Compton2. The Epidemiology of Cannabis Use in the United StatesWilson M. Compton and Beth Han3. The Biology of Cannabis in the Brain, and the Endocannabinoid SystemDavid Louis Atkinson and Jeff. K. Abbott4. Psychotomimetic and Cognitive Effects of Δ9-Tetrahydrocannabinol in Laboratory SettingsJohn D. Cahill, Swapnil Gupta, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza5. Psychotomimetic and Cognitive Effects of Cannabis Use in the General PopulationNadia Solowij6. Effects of Cannabis Use among those with SchizotypyAngelo B. Cedeno7. Effects of Cannabis Use among those at Clinical High Risk for SchizophreniaBrian O'Donoghue, Meredith McHugh, Barnaby Nelson, and Patrick McGorry8. Cannabis-Induced Psychotic DisordersLuca Pauselli9. Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic DisordersPapanti Duccio, Schifano Fabrizio, and Orsolini Laura10. Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic DisordersJodi M. Gilman, Sara M. Sobolewski, and Anne Eden Evins11. Cannabis Use as a Determinant of Earlier Age at Onset of Schizophrenia and Related Psychotic DisordersClaire Ransay Wan and Beth Broussard12. The Prevalence of Cannabis Use, and Effects on Course and Outcomes, among Individuals with Schizophrenia and Related Psychotic DisordersAna Fresán, Rebeca Robles-García, and Carlos-Alfonso Tovilla-Zarate13. The Treatment of Cannabis Use Disorders among Individuals with Psychotic DisordersPeter Bosanac, Ana Lusicic, and David J. Castle14. Cannabidiol as a Potential Novel Therapeutic Agent for Psychotic DisordersSerena Deiana and Erica Zamberletti

What People are Saying About This

From the Publisher

The only book available that explores the relationship between cannabis and schizophrenia

From the B&N Reads Blog

Customer Reviews